WBA Apr 2025 17.500 call
| Previous close | 0.2200 |
| Open | 0.2100 |
| Bid | 0.1200 |
| Ask | 0.2500 |
| Strike | 17.50 |
| Expiry date | 2025-04-17 |
| Day's range | 0.1900 - 0.2100 |
| Contract range | N/A |
| Volume | |
| Open interest | 657 |
ZacksAssessing WBA Before Q4 Earnings: How Should You Play the Stock?
A challenging retail environment and pharmacy trends are expected to cloud Walgreens' performance in the fourth quarter of fiscal 2024.
ReutersWalgreens names Optum's Jason Stenta as chief commercial officer
Walgreens Boots Alliance named ex-Optum executive Jason Stenta as the company's chief commercial officer on Monday. Stenta will lead the company's commercial growth strategy and developing its business-to-business healthcare services, Walgreens said. He has also been tasked with improving partnerships with payers such as insurers, as well as health system providers and life sciences companies, the company added.
Business WireWalgreens Appoints Jason Stenta as SVP and Chief Commercial Officer
DEERFIELD, Ill., October 07, 2024--Walgreens, an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, today announced the appointment of Jason Stenta as SVP and chief commercial officer. In this new role, Stenta will lead the company’s commercial growth strategy, driving development and commercialization of B2B healthcare services built on the company’s core assets, and enhancing partnerships with payers, health system providers and life science
